$AREN
Arena Group Holdings, Inc. Stock $aren

$aren Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000114420418028826 Filed on May 15, 2018

Income Statement

Concept	2017 Q4	2017	2016 Q4
Revenue	$70.00K	$77.00K	$0.00
YoY Change
Cost Of Revenue	$950.0K	$1.591M
YoY Change
Gross Profit	-$880.0K	-$1.514M
YoY Change
Gross Profit Margin	-1257.14%	-1965.9%
Selling, General & Admin	$1.080M	$4.721M	$1.550M
YoY Change	-30.32%	166.39%	3000.0%
% of Gross Profit
Research & Development	$10.00K	$114.9K	$410.0K
YoY Change	-97.56%	-72.1%
% of Gross Profit
Depreciation & Amortization	$290.0K	$12.47K	$0.00
YoY Change		3097.18%
% of Gross Profit
Operating Expenses	$1.090M	$4.836M	$1.960M
YoY Change	-44.39%	121.42%	3820.0%
Operating Profit	-$1.970M	-$6.349M
YoY Change
Interest Expense	$60.00K	$65.03K	-$10.00K
YoY Change	-700.0%	-1789.09%	-200.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.910M	-$6.284M	-$1.980M
YoY Change	-3.54%	187.25%	6500.0%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.910M	-$6.284M	-$1.980M
YoY Change	-3.54%	187.25%	6500.0%
Net Earnings / Revenue	-2728.57%	-8161.98%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.06	-$9.268M	-$14.14
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding		23.39M shares

Balance Sheet

Concept	2017 Q4	2017	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$600.0K	$619.3K	$600.0K
YoY Change	0.0%	3.5%	-73.91%
Cash & Equivalents	$3.619M		$598.3K
Short-Term Investments
Other Short-Term Assets	$3.200M	$3.189M	$100.0K
YoY Change	3100.0%	2522.35%	234.14%
Inventory
Prepaid Expenses
Receivables	$53.20K	$53.20K	$0.00
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.861M	$3.861M	$719.9K
YoY Change	436.33%	436.34%	-69.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.688M	$2.688M	$547.8K
YoY Change	390.64%	390.64%
Goodwill
YoY Change
Intangibles	$20.00K		$20.00K
YoY Change	0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.708M	$2.708M	$567.8K
YoY Change	376.88%	376.87%
TOTAL ASSETS
Total Short-Term Assets	$3.861M	$3.861M	$719.9K
Total Long-Term Assets	$2.708M	$2.708M	$567.8K
Total Assets	$6.569M	$6.569M	$1.288M
YoY Change	410.12%	410.11%	-45.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$162.3K	$162.3K	$154.4K
YoY Change	5.15%	5.15%	1502.75%
Accrued Expenses	$222.7K	$150.1K	$54.79K
YoY Change	306.47%	174.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$416.4K	$3.416M	$346.3K
YoY Change	20.25%	886.47%	302.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$416.4K	$3.416M	$346.3K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.416M	$3.416M	$346.3K
YoY Change	886.48%	886.47%	246.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.472M		-$2.188M
YoY Change	287.25%		-96.5%
Common Stock	$285.2K		$220.5K
YoY Change	29.34%		137.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.984M	$3.152M	$772.9K
YoY Change
Total Liabilities & Shareholders Equity	$6.569M	$6.569M	$1.288M
YoY Change	410.12%	410.11%	-45.25%

Cashflow Statement

Concept	2017 Q4	2017	2016 Q4
OPERATING ACTIVITIES
Net Income	-$1.910M	-$6.284M	-$1.980M
YoY Change	-3.54%	187.25%	6500.0%
Depreciation, Depletion And Amortization	$290.0K	$12.47K	$0.00
YoY Change		3097.18%
Cash From Operating Activities	-$1.540M	-$4.194M	-$650.0K
YoY Change	136.92%	268.6%	6400.0%
INVESTING ACTIVITIES
Capital Expenditures	$530.0K	-$2.040M	$430.0K
YoY Change	23.26%	375.63%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$950.0K
YoY Change	-100.0%	-100.0%	313.04%
Cash From Investing Activities	-$530.0K	-$2.040M	$520.0K
YoY Change	-201.92%	-493.34%	126.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.980M	$9.255M	580.0K
YoY Change	586.21%	660.05%
NET CHANGE
Cash From Operating Activities	-1.540M	-$4.194M	-650.0K
Cash From Investing Activities	-530.0K	-$2.040M	520.0K
Cash From Financing Activities	3.980M	$9.255M	580.0K
Net Change In Cash	1.910M	$3.021M	450.0K
YoY Change	324.44%	404.92%	104.55%
FREE CASH FLOW
Cash From Operating Activities	-$1.540M	-$4.194M	-$650.0K
Capital Expenditures	$530.0K	-$2.040M	$430.0K
Free Cash Flow	-$2.070M	-$2.155M	-$1.080M
YoY Change	91.67%	203.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	us-gaap	Cash Cash	619249	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	3860967	USD
CY2017Q4	us-gaap	Assets Assets	6568694	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	162308	USD
CY2017Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	72563	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	416444	USD
CY2017Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	168496	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	285159	USD
CY2017Q4	mven	Common Stock Value To Be Issued CommonStockValueToBeIssued	0	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11170666	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2983754	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6568694	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	174369	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2687727	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	150136	USD
CY2016Q4	us-gaap	Cash Cash	598294	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	719881	USD
CY2016Q4	us-gaap	Assets Assets	1287685	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	154361	USD
CY2017	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	64614	USD
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	137177	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	346327	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	220475	USD
CY2016Q4	mven	Common Stock Value To Be Issued CommonStockValueToBeIssued	9375	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1287685	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	121587	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	547804	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	54789	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4720824	USD
CY2017	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-6284313	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6284313	USD
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	76995	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	114873	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	4835697	USD
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14919232	shares
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1772169	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2183910	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	11173	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1385	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-16406	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3848	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2187758	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	16406	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2187758	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	411741	USD
	us-gaap	Operating Expenses OperatingExpenses	2183910	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.65
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3353282	shares
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	0	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2952	USD
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	977426	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	735099	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1238893	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6250	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1625687	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7947	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4194392	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2039599	USD
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	52783	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	84875	USD
CY2017	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2039599	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2017	mven	Cash Acquired Upon Reverse Recapitalization CashAcquiredUponReverseRecapitalization	0	USD
CY2017	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2017	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2017	mven	Reclssification Of Sharebased Compensation To Website Development Costs ReclssificationOfSharebasedCompensationToWebsiteDevelopmentCosts	614573	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1105769	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	116171	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1137913	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	947351	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	117830	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-69676	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	408819	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	20000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2952	USD
	mven	Cash Acquired Upon Reverse Recapitalization CashAcquiredUponReverseRecapitalization	479624	USD
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	735099	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	35000	USD
	mven	Reclssification Of Sharebased Compensation To Website Development Costs ReclssificationOfSharebasedCompensationToWebsiteDevelopmentCosts	139375	USD
CY2016Q4	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	735099	USD
CY2017	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11865936	shares
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	525110	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	390	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2017	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-64614	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23392138	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22047531	shares
CY2017Q4	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	4403464	USD
CY2017Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	1	pure
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28516009	shares
CY2016Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2952	USD
CY2016Q3	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	0.0002
CY2016Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	7966070	shares
CY2016Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	4094708	shares
CY2017Q4	mven	Recapitalization Number Of Shares Transfer To Escrow Account RecapitalizationNumberOfSharesTransferToEscrowAccount	4094708	shares
CY2017Q4	mven	Number Of Shares In Escrow Subject To Performance Condition NumberOfSharesInEscrowSubjectToPerformanceCondition	4381003	shares
CY2017Q4	mven	Common Stock Share Percentage Escrowed CommonStockSharePercentageEscrowed	0.35	pure
CY2016Q4	mven	Percentage Of Escrow Shares To Be Released Subject To Performance Condition PercentageOfEscrowSharesToBeReleasedSubjectToPerformanceCondition	0.725	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.88
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	175000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2823363	shares
CY2016Q4	mven	Deferred Tax Assets Accrued Liabilities Not Currently Deductible DeferredTaxAssetsAccruedLiabilitiesNotCurrentlyDeductible	64210	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	506259	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	570469	USD
CY2016Q4	mven	Deferred Tax Liabilities Deferred Expense Share Based Compensation DeferredTaxLiabilitiesDeferredExpenseShareBasedCompensation	16625	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	136263	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	417581	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	152888	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-743838	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	373368	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	370470	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	mven	Class Of Warrant Or Rightterm ClassOfWarrantOrRightterm	P5Y
CY2017Q4	mven	Class Of Warrant Or Rightholding Percentage ClassOfWarrantOrRightholdingPercentage	0.05	pure
CY2017Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1169607	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.20
CY2017Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	744105	USD
CY2017Q2	us-gaap	Share Price SharePrice	1.00
CY2017Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3765000	USD
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	735000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53202	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2017Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	14147	USD
CY2016Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	0	USD
CY2017Q4	us-gaap	Deferred Revenue DeferredRevenue	31437	USD
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	0	USD
CY2017Q4	mven	Investor Demand Payablenoncurrent InvestorDemandPayablenoncurrent	3000000	USD
CY2016Q4	mven	Investor Demand Payablenoncurrent InvestorDemandPayablenoncurrent	0	USD
CY2017Q4	us-gaap	Liabilities Liabilities	3416444	USD
CY2016Q4	us-gaap	Liabilities Liabilities	346327	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.  Actual results could materially differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28516009	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22047531	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22047531	shares
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Concentrations of Credit Risk</i></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	1590636	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2017	us-gaap	Gross Profit GrossProfit	-1513641	USD
	us-gaap	Gross Profit GrossProfit	0	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	524721	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	390	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	53202	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2017	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	14147	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	31437	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2017	mven	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	5772345	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3212837	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	548194	USD
CY2017	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P1Y
CY2017Q4	mven	Deferred Tax Assets Accrued Liabilities Not Currently Deductible DeferredTaxAssetsAccruedLiabilitiesNotCurrentlyDeductible	38328	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1544591	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1716625	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1353207	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	363418	USD
CY2017Q4	mven	Deferred Tax Liabilities Deferred Expense Share Based Compensation DeferredTaxLiabilitiesDeferredExpenseShareBasedCompensation	10268	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	353150	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2136666	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	378611	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.34
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	27750	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2176637	shares
CY2017Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5000000	shares
CY2016Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4.13607	pure
CY2017Q4	mven	Percentage Of Escrow Shares To Be Released Subject To Performance Condition PercentageOfEscrowSharesToBeReleasedSubjectToPerformanceCondition	0.56	pure
CY2017Q4	mven	Recapitalization Number Of Shares Transfer To Escrow Account Subject To Buy Back Right RecapitalizationNumberOfSharesTransferToEscrowAccountSubjectToBuyBackRight	1927641	shares
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3500000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M6D
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3631	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	130075	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	USD
CY2017	mven	Stock Issued During Period Value Warrants Issued StockIssuedDuringPeriodValueWarrantsIssued	126286	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	0	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2240260	USD
CY2017Q4	us-gaap	Deferred Set Up Costs Current DeferredSetUpCostsCurrent	14147	USD
CY2017Q4	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	592000	USD
CY2017Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	142000	USD
CY2017Q4	us-gaap	Other Commitment OtherCommitment	734000	USD
CY2017	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2018-04-30
CY2017Q4	us-gaap	Short Term Lease Commitment Amount ShortTermLeaseCommitmentAmount	25000	USD
CY2017Q4	mven	Aggregate Remaining Commitment AggregateRemainingCommitment	734000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	500000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	350000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3650500	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2696668	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1303832	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	679255	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.05
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.36
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.29
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.48
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.48
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.60
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M6D
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	583000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	583000	USD
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	233000	USD
CY2017	mven	Increase Decrease Deferred Tax IncreaseDecreaseDeferredTax	838000	USD
CY2017	mven	Payments Of Guarantees Obligation PaymentsOfGuaranteesObligation	560000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2022-10-19
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	12517152	shares
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	0	shares
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	6979596	shares
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.41
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.41
CY2017	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>2.   Basis of Presentation</b></div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">TheMaven Network, Inc. was incorporated in Nevada on July 22, 2016, under the name “Amplify Media, Inc.” On July 27, 2016, the corporate name was amended to “Amplify Media Network, Inc.” and on October 14, 2016, the corporate name was changed to “TheMaven Network, Inc.”. On March 5, 2018 the corporate name was changed to Maven Coalition, Inc. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">TheMaven, Inc. was formerly known as Integrated Surgical Systems, Inc., a Delaware corporation (“<i>Integrated</i>”). From June 2007 until November 4, 2016, Integrated was a non-active “shell company” as defined by regulations of the Securities and Exchange Commission (SEC). On August 11, 2016, Integrated entered into a loan to Subsidiary that provided initial funding totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">735,099</font> for the Subsidiary’s operations. On October 14, 2016 Integrated entered into a Share Exchange Agreement (the “<i>Share Exchange Agreement</i>”) with Subsidiary and the shareholders of Subsidiary, holding all of the issued and outstanding shares of Subsidiary (collectively, “<i>Subsidiary Shareholders</i>”). The Share Exchange Agreement was amended on November 4, 2016 to include certain newly issued shares of Subsidiary in the transaction and make related changes to the agreement and the Share Exchange was consummated. The transaction resulted in Parent acquiring Subsidiary by the exchange of all of the outstanding shares of Subsidiary for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12,517,152</font> newly issued shares of the common stock, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.01</font> par value (the “<i>Common Stock</i>”) of Parent, representing approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 56.7</font>% of the issued and outstanding shares of Common Stock immediately after the transaction. The transaction is referred to as the “Recapitalization.” The Recapitalization was consummated on November 4, 2016, as a result of which <font style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Maven Coalition</font>, Inc. became a wholly owned subsidiary of Integrated (the “<i>Closing</i>”). The note payable between Integrated and Subsidiary was an interdependent transaction with the Recapitalization and was ultimately cancelled upon closing of the Recapitalization. On December 2, 2016, Integrated amended its Certificate of Incorporation to change its name from “Integrated Surgical Systems, Inc.” to “TheMaven, Inc.”</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">From June 2007 until the closing of the Recapitalization, Integrated was a non-active “shell company” as defined by regulations of the SEC and, accordingly, the Recapitalization was accounted for as a reverse recapitalization rather than a business combination. As the Subsidiary is deemed to be the purchaser for accounting purposes under reverse recapitalization accounting, the Company’s financial statements are presented as a continuation of Subsidiary, and the accounting for the Recapitalization is equivalent to the issuance of stock by Subsidiary for the net monetary assets of Parent as of the Closing accompanied by a recapitalization.  See Note 9 for summary of the assets acquired, transaction costs and the consideration exchanged in the Recapitalization.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017	us-gaap	Adjustment For Amortization AdjustmentForAmortization	512252	USD
CY2017	us-gaap	Depreciation Depreciation	12469	USD
CY2016	us-gaap	Depreciation Depreciation	390	USD
CY2016	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	USD
CY2017	mven	Share Based Compensations Arrangements Share Based Payment Award Options Grants In Period Remaining Contractual Term ShareBasedCompensationsArrangementsShareBasedPaymentAwardOptionsGrantsInPeriodRemainingContractualTerm	P5Y
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y4M6D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M6D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y11M23D
CY2017	mven	Share Based Compensations Arrangements Share Based Payment Award Options Forfeitured In Period Remaining Contractual Term ShareBasedCompensationsArrangementsShareBasedPaymentAwardOptionsForfeituredInPeriodRemainingContractualTerm	P4Y1M6D
CY2017	mven	Share Based Compensations Arrangements Share Based Payment Award Options Exercised In Period Remaining Contractual Term ShareBasedCompensationsArrangementsShareBasedPaymentAwardOptionsExercisedInPeriodRemainingContractualTerm	P0Y
CY2017Q4	mven	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Outstanding Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedOutstandingNumber	5537556	shares
CY2017Q4	mven	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageExercisePrice	0.41
CY2017	mven	Sharebasedcompensationarrangementbysharebasedpaymentawardoptionscashlessexercisesinperiod Sharebasedcompensationarrangementbysharebasedpaymentawardoptionscashlessexercisesinperiod	150000	shares
CY2017	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6254946	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9254946	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1217675	USD
CY2017	us-gaap	Proceeds From Deposits From Customers ProceedsFromDepositsFromCustomers	3000000	USD
	us-gaap	Proceeds From Deposits From Customers ProceedsFromDepositsFromCustomers	0	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3020955	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	598294	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	598294	USD
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3619249	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	5537556	shares
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.41
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	837699	USD
	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3000000	USD
CY2016Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2017	mven	Net Cash Proceeds NetCashProceeds	2700000	USD
CY2017Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	446000	USD
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	296000	USD
CY2016	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P1Y
CY2015Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	138562	USD
CY2016	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-1385	USD
CY2017	us-gaap	Stock Issued1 StockIssued1	482600	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.060	pure
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.171	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.133	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.147	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.169	pure
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2017Q4	mven	Future Minimum Sublease Rentals Next Twelve Months FutureMinimumSubleaseRentalsNextTwelveMonths	113000	USD
CY2017Q4	mven	Future Minimum Sublease Rentals Within Two Years FutureMinimumSubleaseRentalsWithinTwoYears	233000	USD
CY2017Q4	mven	Future Minimum Sublease Rentals Within Three Years FutureMinimumSubleaseRentalsWithinThreeYears	265000	USD
CY2017Q4	mven	Future Minimum Sublease Rentals Within Four Years FutureMinimumSubleaseRentalsWithinFourYears	227000	USD
CY2017Q4	mven	Future Minimum Sublease Expenses Total FutureMinimumSubleaseExpensesTotal	838000	USD
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>1.   Nature of Operations</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">TheMaven, Inc. (“Parent”) and Maven Coalition, Inc. (“Subsidiary”) (collectively “TheMaven” or the “Company”) are developing an exclusive network of professionally managed online media channels, with an underlying technology platform. Each channel will be operated by a invite only Channel Partner drawn from subject matter experts, reporters, group evangelists and social leaders. Channel Partners will publish content and oversee an online community for their respective channels, leveraging a proprietary, socially-driven, mobile-enabled, video-focused technology platform to engage niche audiences within a single network.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name	View Source	Status
0001144204-18-028826-index-headers.html	Edgar Link	pending
0001144204-18-028826-index.html	Edgar Link	pending
0001144204-18-028826.txt	Edgar Link	pending
0001144204-18-028826-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mven-20171231.xml	Edgar Link	completed
mven-20171231.xsd	Edgar Link	pending
mven-20171231_cal.xml	Edgar Link	unprocessable
mven-20171231_def.xml	Edgar Link	unprocessable
mven-20171231_lab.xml	Edgar Link	unprocessable
mven-20171231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv491042_10k.htm	Edgar Link	pending
tv491042_ex21-1.htm	Edgar Link	pending
tv491042_ex31-1.htm	Edgar Link	pending
tv491042_ex31-2.htm	Edgar Link	pending
tv491042_ex32-1.htm	Edgar Link	pending
tv491042_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREN
Arena Group Holdings, Inc. Stock $aren

2017 Q4 Form 10-K Financial Statement

#000114420418028826 Filed on May 15, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREN Arena Group Holdings, Inc. Stock $aren

2017 Q4 Form 10-K Financial Statement

#000114420418028826 Filed on May 15, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREN
Arena Group Holdings, Inc. Stock $aren